✦ LIBER ✦

Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors

✍ Scribed by Katalin Monostory; Eszter Hazai; László Vereczkey

Book ID: 113517041
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 120 KB
Volume: 147
Category: Article
ISSN: 0009-2797
DOI: 10.1016/j.cbi.2004.03.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chlormethiazole inhibition of cytochrome

Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans

✍ A C Gebhardt; D Lucas; J Menez; H K Seitz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Chlormethiazole is a sedative and anticonvulsive drug used in the treatment of alcohol withdrawal. Because it had been reported that chlormethiazole inhibits the alcohol-inducible cytochrome P450 2E1 in rat liver, we investigated the in vivo and in vitro effect of this drug on cytochrome P450 2E1 in

Chlormethiazole inhibition of cytochrome

Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans

✍ AC Gebhardt; D Lucas; J Menez; HK Seitz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Both Cytochromes P450 2E1 and 3A Are Inv

Both Cytochromes P450 2E1 and 3A Are Involved in the O-Hydroxylation of p -Nitrophenol, a Catalytic Activity Known To Be Specific for P450 2E1

✍ Zerilli, Alain; Ratanasavanh, Damrong; Lucas, Danièle; Goasduff, Thierry; Dréano 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 309 KB

Inhibition of desipramine hydroxylation

Inhibition of desipramine hydroxylation (cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: Relation to drug interactions in vivo

✍ Lisa L. von Moltke; David J. Greenblatt; Su Xiang Duan; Johanna P. Daily; Jerold 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

In vitro comparative inhibition profiles

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

✍ C. Transon; T. Leemann; P. Dayer 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 343 KB